Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to make good progress in 2025 with key regulatory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback